Bengene Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 9.70 M
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.45 Cr
- Revenue Growth -33.27%
- Profit Growth 72.39%
- Ebitda 30.84%
- Net Worth 34.79%
- Total Assets 18.19%
About Bengene Life Sciences
Bengene Life Sciences Private Limited (BLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 February 2019 (Five years and 11 months 14 days old ). Its registered office is in Villupuram, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.70 M.
The company currently has active open charges totaling ₹1.45 Cr.
Senthiladipan Venkatachalam, Perumal Shanmugam, Dhanabal Lakshmanan, and One other member serve as directors at the Company.
Company Details
-
Location
Villupuram, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24290TN2019PTC127701
-
Company No.
127701
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Feb 2019
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
What products or services does Bengene Life Sciences Private Limited offer?
Bengene Life Sciences Private Limited offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Hand Sanitizer & Disinfectant, Anti Infective Drugs & Medicines, Antibiotic Injection, Antibacterial Drugs.
Who are the key members and board of directors at Bengene Life Sciences?
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Senthiladipan Venkatachalam
![]() |
Director | 25-Feb-2019 | Current |
Perumal Shanmugam
![]() |
Additional Director | 30-Apr-2019 | Current |
Dhanabal Lakshmanan
![]() |
Director | 25-Feb-2019 | Current |
Ponniah Saravanaperumal
![]() |
Director | 25-Feb-2019 | Current |
Financial Performance of Bengene Life Sciences.
Bengene Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.27% decrease. The company also saw a substantial improvement in profitability, with a 72.39% increase in profit. The company's net worth Soared by an impressive increase of 34.79%.
![Graph illustrating revenue growth over time](/Images/financial/revenue-growth.webp)
![Graph showing profit and loss trends over time](/Images/financial/profit-loss.webp)
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Bengene Life Sciences?
In 2023, Bengene Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
![Shareholding Indicator graph](/Images/tcc-login/Shareholding-Indiacator-1200.webp)
Charges (Loans)
₹1.45 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 1.45 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
20 Mar 2023 | Others | ₹4.70 M | Open |
03 Feb 2022 | Others | ₹9.80 M | Open |
How Many Employees Work at Bengene Life Sciences?
Unlock and access historical data on people associated with Bengene Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
![Graph showing employee growth trends](/Images/tcc-login/Employee-Graph.webp)
Deals i
![Graph showing company valuation over time](/Images/tcc-login/Valuation-Graph-small.webp)
Gain comprehensive insights into the Deals and Valuation data of Bengene Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bengene Life Sciences's trajectory.
Rating
![Graph displaying rating trends over time](/Images/tcc-login/Rating-Graph-small.webp)
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
![Alert Indicator](/Images/tcc-login/Alert-Indicator-small.webp)
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.